ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional Accepts healthy volunteers

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

ClinicalTrials.gov ID: NCT07500506

Public ClinicalTrials.gov record NCT07500506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A FIFTH DOSE OF 6-VALENT OSPA-BASED LYME DISEASE VACCINE, VLA15, IN HEALTHY PARTICIPANTS ≥7 YEARS OF AGE

Study identification

NCT ID
NCT07500506
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,712 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Biological
  • VLA15 Biological

Biological

Eligibility (public fields only)

Age range
7 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2026
Primary completion
Dec 3, 2026
Completion
Dec 3, 2026
Last update posted
Mar 29, 2026

2026

United States locations

U.S. sites
11
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
MaineHealth Pen Bay Hospital Rockport Maine 04856
ActivMed Practices and Research Methuen Massachusetts 01844
IMA Clinical Research Warren Warren Township New Jersey 07059
Smith Allergy and Asthma Specialists Cortland New York 13045
Smith Allergy & Asthma Specialists Horseheads New York 14845
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18) Pittsburgh Pennsylvania 15236
Guthrie Medical Group, P.C. Sayre Pennsylvania 18840
Robert Packer Hospital Sayre Pennsylvania 18840
Northeast Clinical Trials Group Scranton Pennsylvania 18510
Preferred Primary Care Physicians Uniontown Pennsylvania 15401
Amherst Family Practice, P.C. Winchester Virginia 22601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07500506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07500506 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →